Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €15.45 EUR
Change Today +0.285 / 1.88%
Volume 0.0
TAY On Other Exchanges
Symbol
Exchange
Berlin
Tokyo
OTC US
OTC US
OTC US
As of 2:37 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

2-6-18, Kitahama

Chuo-ku

Osaka, 541-8505

Japan

Phone: 81 6 6205 5085

Fax:

Tanabe Seiyaku Co., Ltd. engages in the manufacturing and sale of pharmaceuticals, centered on ethical drugs in Japan. It develops a range of drugs for treating hypertension and heart diseases. As of March 31, 2005, the company comprises 19 subsidiaries and 6 affiliates. The company operates in two divisions that include Pharmaceuticals and Other products. Pharmaceuticals In Pharmaceuticals division, the company offers ethical drugs, over-the-counter drugs, and diagnostic agents. In the Therapeutic field, the company offers products in following categories that include Central and Peripheral Nervous System Drugs under the brand name Ceredist; Cardiovascular and Respiratory Drugs under the brands Herbesser, Tanatril, Sermion, Maintate, Lochol, and Adona AC-17; Digestive System Drugs under the brands Gastrom and Cerekinon; Hormones under Flucoat F and Topsym Tonic brands; Nutritional Supplements under the Fulcaliq, Unicaliq, and Aspara Drinks brands; Antibiotics and Biological Products under the brand name Modacin, Remicade, and Vaccine; Chemotherapeutics under Denosine brand; Diagnostic Agents under Proscope brand; and Others under Talion and Nanpao brand. Consumer health care products include Nan Pao, which offers a balanced blend of 31 herbal and other natural medicines; Aspara Mega nutritional tonics; SmartEye eye drops, which use a developed side drop container; and Tanabe Ichoyaku Choritsu. In addition, Aspara brand drinks are sold at pharmacies, convenience stores, and vending machines throughout the country. Other The company offers fine chemicals, food additives, machinery, information services, and advertising. In fine chemical products, the company provides a range of related industries in Japan and overseas with intermediates for use in pharmaceuticals, agricultural chemicals, dyes, and products used in the IT industry. It also uses original production technology to make d-biotin, which it sells as a pharmaceutical, food additive, or feed additive in Japan, as well as in Europe and the United States. In products for food companies, the company provides vitamins for use as food additives, amino acids and other health food related products, organic acids, preservatives, and enzymes. Sales The company offers its products to patients, doctors, pharmacists, healthcare personnel and wholesalers. The company also operates in the United States, Europe, and Asia. History Tanabe Seiyaku Co., Ltd. was established in 1678.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TAY:GR €15.45 EUR +0.285

TAY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TAY.
View Industry Companies
 

Industry Analysis

TAY

Industry Average

Valuation TAY Industry Range
Price/Earnings 26.7x
Price/Sales 2.9x
Price/Book 1.5x
Price/Cash Flow 20.9x
TEV/Sales 2.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MITSUBISHI TANABE PHARMA, please visit www.mt-pharma.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.